Search results for "FARMACEUTICO"

showing 10 items of 419 documents

Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects.

2013

Naltrexone is widely used in the treatment of opiate addiction but its current peroral administration is characterized by low bioavailability with various side effects. The development of a long-acting transbuccal delivery device (IntelliDrug) for NLX may be useful to improve patient compliance and the therapy effectiveness. The aims of the study are (a) to test basic safety and effectiveness of controlled transbuccal drug delivery on human subjects; (b) to compare NLX bioavailability following transbuccal delivery vs per os conventional delivery; and (c) to test the hypothesis that transbuccal delivery is more efficient than the conventional route. In this randomized cross-over pilot study…

Naltrexone HydrochlorideAdultMaleAdolescentNarcotic AntagonistsPharmaceutical ScienceAddictionBiological AvailabilityPharmacologySmoking cessationNaltrexonelaw.inventionTransbuccal drug deliveryYoung AdultDrug Delivery SystemsRandomized controlled triallawmedicineHumansNaltrexone hydrochlorideNLXCross-Over Studiesbusiness.industryAdministration BuccalTransmucosal deliveryBuccal administrationMiddle AgedCrossover studyNaltrexoneBioavailabilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAnesthesiaDelayed-Action PreparationsDrug deliveryMouth ProtectorsFemalebusinessmedicine.drugInternational journal of pharmaceutics
researchProduct

Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features

2006

Abstract In transbuccal absorption a major limitation could be the low permeability of the mucosa which implies low drug bioavailability. The ability of naltrexone hydrochloride (NLX) to penetrate a resembling histologically human buccal mucosa was assessed and the occurrence of any histomorphological changes observed. We used reconstituted human oral (RHO) non-keratinised epithelium as mucosal section and a Transwell diffusion cells system as bicompartmental model. Buccal permeation was expressed in terms of drug flux ( J s ) and permeability coefficients ( K p ). Data were collected using both artificial and natural human saliva. The main finding was that RHO does not restrain NLX permeat…

Naltrexone HydrochlorideSalivaTissue FixationCell SurvivalNarcotic AntagonistsPharmaceutical SciencePharmacologySettore MED/08 - Anatomia PatologicaEpitheliumPermeabilityAbsorptionDiffusionExcipientsSettore MED/28 - Malattie OdontostomatologichemedicineHumansNaltrexone hydrochlorideNLXIontophoresiBuccal permeationTransbuccal absorptionParaffin EmbeddingIontophoresisChemistryNarcotic antagonistMouth MucosaAdministration BuccalGeneral MedicineBuccal administrationIontophoresisPermeationReconstituted human oral epithelium (RHO)Electric StimulationNaltrexoneEpitheliummedicine.anatomical_structurePenetration enhancersSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoData Interpretation StatisticalBiophysicsBiotechnology
researchProduct

Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs.

2010

Naltrexone (NLX), an opioid antagonist, is widely used in the treatment of opiate addiction, alcoholism and smoking cessation. Its current peroral administration induces various adverse side effects and has limited efficacy since bioavailability and patient compliance are poor. The development of a long-acting drug delivery system of NLX may overcome the current drawbacks and help in the improvement of treatment of addiction. The primary endpoints of this study were: a) to compare the NLX bioavailability and pharmacokinetics after delivering a single transbuccal dose, released by a prototype of intraoral device, versus an intravenous (I.V.) bolus of the same drug dose; b) to verify the func…

Naltrexone HydrochlorideSwineNarcotic AntagonistsSettore MED/50 - Scienze Tecniche Mediche ApplicatePharmaceutical ScienceBiological AvailabilityPharmacologyNaltrexoneBolus (medicine)Drug Delivery SystemsPharmacokineticsSettore MED/28 - Malattie OdontostomatologicheOral administrationMedicineAnimalsNaltrexone hydrochlorideIontophoresiNLXbusiness.industryNarcotic antagonistAdministration BuccalTransmucosal deliveryBuccal administrationEquipment DesignNaltrexoneSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoIntelliDrug intraoral deviceAnesthesiaFemalePorcine buccal mucosabusinessmedicine.drugJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Production of polymeric micro- and nanostructures with tunable properties as pharmaceutical delivery systems

2020

Abstract The production of novel graft copolymers based on poly-e-caprolactone (PCL) and polyaspartamide are useful to realize structures for potential biomedical applications. Here, the synthesis of pegylated PCL/polyhydroxyethyl aspartamide (PHEA) graft copolymers (PHEA-g-SUCC-PCL-g-PEG) with tunable composition, was achieved by followpling a synthetic strategy that involved first the grafting of preformed PCL on PHEA backbone, then polyethylen glycol (PEG), by using 1,1′-carbonyldiimidazole (CDI) to speed up the condensation reaction. Graft copolymers with a Derivatization Degree (DD) in PCL ranging between 1.1 and 4.4 mol% were obtained, and processable with different technologies for t…

NanostructureMaterials sciencePolymers and PlasticsMicrofluidicsNanoparticlemacromolecular substances02 engineering and technology010402 general chemistry01 natural sciencesPEG ratioMaterials ChemistryCopolymerOrganic Chemistrytechnology industry and agricultureαβ-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA)equipment and suppliesmusculoskeletal system021001 nanoscience & nanotechnologyCondensation reactionGrafting0104 chemical sciencesGraft copolymerChemical engineeringMicrofluidicMicroparticlePoly-ε-caprolactone (PCL)Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanoparticles0210 nano-technologyNanoprecipitation
researchProduct

CURCUMIN ENTRAPPED INTO LIPID NANOSYSTEMS IMPROVES INHIBITION OF NEUROBLASTOMA CANCER CELL GROWTH ACTIVATING HSP70 PROTEIN

2010

Nanostructured Lipid Carriers Curcumin Drug release Human neuroblastoma cells Hsp70 protein CancerSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Lipid nanocarriers containing esters prodrugs of Flurbiprofen. Preparation, physical-chemical characterization and biological studies.

2013

In this paper, the preparation, chemical-physical, technological and in vitro characterization of nanostructured lipid carriers (NLC) carrying R-flurbiprofen ester prodrugs, were analyzed for a potential pharmaceutical application. R-flurbiprofen was chosen as a model drug because it has been found to play an effective role in counteracting secretases involved in neurodegenerative diseases, although it does not cross the Blood Brain Barrier (BBB). In this study, two R-flurbiprofen ester prodrugs (ethyl and hexyl) were successfully synthesized and entrapped into non-pegylated and pegylated NLC. The obtained systems showed average diameters in the colloidal size range, negative zeta potential…

Nanostructured Lipid CarriersMaterials scienceMagnetic Resonance SpectroscopyR-Flurbiprofen Ester ProdrugCell SurvivalFlurbiprofenStatic ElectricityBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringEsteraseBrain TargetingCell Line TumormedicineZeta potentialHumansGeneral Materials ScienceProdrugsViability assayParticle SizeCytotoxicityCell ShapeDrug CarriersNanostructured Lipid CarrierChromatographyDose-Response Relationship DrugEstersProdrugR-Flurbiprofen Ester ProdrugsLipidsIn vitroNanostructuresCitotoxicity Assays.BiochemistryFlurbiprofenSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryCitotoxicity AssaysDrug Deliverymedicine.drug
researchProduct

Galactosylated polymeric carriers for liver targeting of sorafenib

2014

In this paper, we describe the preparation of liver-targeted polymeric micelles potentially able to carry sorafenib to hepatocytes for treatment of hepatocarcinoma (HCC), exploiting the presence of carbohydrate receptors, ASGPR. These micelles were prepared starting from a galactosylated polylactide-polyaminoacid conjugate. This latter was obtained by chemical reaction of α,β-poly(N-2-hydroxyethyl) (2-aminoethylcarbamate)-d,l-aspartamide (PHEA-EDA) with polylactic acid (PLA), and subsequent reaction with lactose, leading to PHEA-EDA-PLA-GAL copolymer. Liver-targeted sorafenib-loaded micelles were obtained in aqueous media at low PHEA-EDA-PLA-GAL copolymer concentration value with nanometer …

NiacinamideSorafenibBiodistributionPolyestersBiological AvailabilityPharmaceutical ScienceAntineoplastic AgentsPharmacologyKidneyMicellechemistry.chemical_compoundPolylactic acidHepatic cell-targeted carriersmedicineZeta potentialAnimalsLungneoplasmsMicellesDrug CarriersActive targetingPhenylurea CompoundsHepatic cell-targeted carrierGalactoseActive targeting; Galactosylation; Hepatic cell-targeted carriers; Polymeric micellesSorafenibEthylenediaminesdigestive system diseasesMice Inbred C57BLLiverBiochemistrychemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoGalactosylationDrug deliveryPolymeric micellesFemalePeptidesDrug carrierSpleenmedicine.drugConjugateInternational Journal of Pharmaceutics
researchProduct

Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells

2015

Here, the potential of two nanostructured lipid carriers (NLC) for controlled release of sorafenib was evaluated. The obtained systems showed characteristics suitable as drug delivery systems for the treatment of hepatocellular carcinoma (HCC) through parenteral administration. The use of a mixture between a solid lipid (tripalmitin) with a liquid lipid (Captex 355 EP/NF or Miglyol 812) to prepare NLC systems could give a higher drug loading capacity and a longer term stability during storage than that obtained by using only solid lipids. The obtained nanoparticles showed a nanometer size and high negative zeta potential values. Scansion electron microscopy (SEM) of the sorafenib loaded NLC…

NiacinamideSorafenibDrugCell Survivalmedia_common.quotation_subjectnanostructured lipid carriersPharmaceutical ScienceAntineoplastic AgentsPharmacologyHemolysischemistry.chemical_compoundNanostructured lipid carriers Sorafenib Drug release Angiogenesis inhibitor HepatocarcinomamedicineZeta potentialHumansParticle SizeChromatography High Pressure LiquidTriglyceridesdrug releasemedia_commonDrug CarriersPhenylurea CompoundsHep G2 Cellsmedicine.diseaseLipidsControlled releasedigestive system diseasesIn vitroDrug Liberationangiogenesis inhibitorchemistryhepatocarcinomaSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsHepatocellular carcinomaTripalmitinDrug deliveryMicroscopy Electron ScanningNanoparticlessorafenibCaprylatesmedicine.drug
researchProduct

Nitrogen and sulfur co-doped carbon nanodots toward bovine hemoglobin: A fluorescence quenching mechanism investigation

2018

A deep understanding of the molecular interactions of carbon nanodots with biomacromolecules is essential for wider applications of carbon nanodots both in vitro and in vivo. Herein, nitrogen and sulfur co-doped carbon dots (N,S-CDs) with a quantum yield of 16% were synthesized by a 1-step hydrothermal method. The N,S-CDs exhibited a good dispersion, with a graphite-like structure, along with the fluorescence lifetime of approximately 7.50 ns. Findings showed that the fluorescence of the N,S-CDs was effectively quenched by bovine hemoglobin as a result of the static fluorescence quenching. The mentioned quenching mechanism was investigated by the Stern-Volmer equation, temperature-dependent…

NitrogenQuantum yieldchemistry.chemical_element010402 general chemistryPhotochemistry01 natural sciencesHemoglobinsStructural BiologyQuantum DotsAnimalsMolecular Biologybovine hemoglobinQuenching (fluorescence)010401 analytical chemistryFluorescenceSulfurAcceptorNitrogenCarbon0104 chemical sciencesquenching mechanismchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoCattlefluorescenceDispersion (chemistry)CarbonSulfurnitrogen and sulfur co-doped carbon dotsJournal of Molecular Recognition
researchProduct

STRATEGIE DI DIREZIONAMENTO ALL’EPATOCARCINOMA DI FARMACI ANTITUMORALI MEDIANTE SISTEMI NANOPARTICELLARI E DI VISUALIZZAZIONE IN CELLULE TUMORALI DEL…

Lo scopo di questo lavoro di tesi è stato quello di realizzare nuovi sistemi nanoparticellari per il direzionamento di farmaci o di agenti per l’imaging, potenzialmente utilizzabili per la terapia e/o per la diagnosi dell’epatocarcinoma (HCC), in particolare per quelle forme caratterizzate dall’overespressione del recettore di membrana degli epatociti ASGP-R o del recettore mitocondriale TSPO. In particolare, nel capitolo 2 sono state descritte la sintesi, la caratterizzazione chimico fisica, la capacità di internalizzazione cellulare e l’efficacia antitumorale di un nuovo sistema nanoparticellare, costituito da un dendrimero a struttura poli-amido-aminica (PAMAM) di quarta generazione, opp…

PAMAM dendrimerLactobionic acidQD nanoparticleTSPO receptorSPIONimagingSorafenibASGPR receptor; TSPO receptor; HEPATOCELLULAR CARCINOMA; Lactobionic acid; Sorafenib; PAMAM dendrimer; QD nanoparticles; Micelles pegilated; SPION; magnetic targeting;imaging;magnetic targetingASGPR receptorMicelles pegilatedSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoHEPATOCELLULAR CARCINOMA
researchProduct